Cancer vaccines have been under investigation in numerous ongoing clinical trials of BC such as dendritic cells, HER2-based vaccines, and peptide-targeting neoantigen vaccines (Hamilton et al., 2012; Fennemann et al., 2019). Here, ERBB2 is linked to breast cancer.